Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives

In this review, we draw from observational studies, treatment guidelines and our own clinical experience to describe approaches to monitoring and management of immune checkpoint inhibitor (ICI)-induced inflammatory arthritis, including polymyalgia rheumatica. This condition occurs in about 4% of ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Karmela K, Bass, Anne R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148583/
https://www.ncbi.nlm.nih.gov/pubmed/35642215
http://dx.doi.org/10.2147/JIR.S282600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148583/
https://www.ncbi.nlm.nih.gov/pubmed/35642215
http://dx.doi.org/10.2147/JIR.S282600

Ejemplares similares